Effect of Insulin Therapy on Established Diabetic Nephropathy in Rats

The effectiveness of insulin therapy on early diabetic nephropathy has not been established. In this study we examined the influence of continuous subcutaneous insulin on the progression of established nephropathy in streptozocin-induced diabetic rats. Normal controls and diabetic rats were studied for 11 mo. During the first 6 mo, all the diabetic rats received 2 U protamine zinc insulin s.c. twice weekly. During the last 5 mo of study, diabetic rats either continued on the occasional subcutaneous insulin regimen or received regular insulin by continuous subcutaneous infusion. Six months after the initiation of the study, the diabetic rats were severely hyperglycemie, and their relative mesangial areas had increased. Continued poor glycemie control in the rats receiving occasional insulin was associated with relative increased mesangial area (25.2 ± 1.0% of glomerular area) and significant proteinuria (148 ± 17 mg/24 h) compared with normal controls. In contrast, the use of continuous subcutaneous insulin therapy with improved glycemie control arrested mesangial changes (19.5 ± 1.4% of glomerular area) and prevented the excessive proteinuria (71 ±13 mg/24 h). Indeed, these parameters did not differ from age-matched controls. We conclude that in the rat, continuous subcutaneous insulin therapy instituted after the development of early glomerular pathology is effective in arresting the disease process.